Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
6013.0000 -127.00 (-2.07%)
NSE Jan 20, 2026 15:31 PM
Volume: 204.4K
 

6013.00
-2.07%
BOB Capital Markets Ltd.
Q3 sales/EBITDA/PAT were 0.6%/7.5%/22.3% above our estimates. PAT was higher than estimated due to the adoption of the new tax regime
Divi's Laboratories .. has an average target of 6270.00 from 6 brokers.
More from Divi's Laboratories Ltd.
Recommended